Clinical Trials in Austin

Showing 9741-9760 of 11,561 trials

VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

NCT00291187

The purpose of this study is to determine the safety and efficacy of VEC-162 compared to placebo to improve sleep parameters in a model of insomnia.

Insomnia

Vanda Pharmaceuticals411 participantsStarted Feb 2006

Birmingham, Alabama, United States • Phoenix, Arizona, United States • San Diego, California, United States +16 more locations

COMPLETEDPhase 3< 1 mile

VEC-162 Study in Adult Patients With Primary Insomnia

NCT00548340

The purpose of this study is to evaluate the efficacy and safety of a 5 week double-blind treatment period of VEC-162 as compared to placebo in male and female patients with primary insomnia.

Primary Insomnia

Vanda Pharmaceuticals322 participantsStarted Nov 2007

Birmingham, Alabama, United States • Hot Springs, Arkansas, United States • Little Rock, Arkansas, United States +32 more locations

VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

VEC-162 Study in Adult Patients With Primary Insomnia

Find Trials by Condition in Austin

Experimental Medication For the Treatment of Generalized Anxiety Disorder

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up

A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer

Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%

Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function

Efficacy and Safety Study of an Oral Contraceptive in Healthy Females

Pharmacodynamics of CNP During Growth Hormone Treatment